140
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting

, , , , , , , & ORCID Icon show all
Pages 105-116 | Received 06 Nov 2023, Accepted 25 Jan 2024, Published online: 05 Mar 2024